Oxford Nanopore gets bioMerieux backing as announces clinical foray

Oxford Nanopore Technologies PLC shares surged after it received GBP70 million worth of backing from in vitro diagnostics partner bioMerieux SA.

Oxford Nanopore also backed its 2026 breakeven target,...

Related Keywords

Gordon Sanghera ,Eric Cunha ,Oxford Nanopore ,Alliance News Ltd ,Alliance News ,Oxford Nanopore Technologies ,Nanopore Technologies ,Mayo Clinic ,Nanopore Chief Executive Officer Gordon Sanghera ,All Rights ,Markets ,